Fecal transplant from vaginally seeded infants decreases intraabdominal adiposity in mice

Sivaranjani Namasivayam1, Curtis Tilves2,3, Hua Ding4

  • 1Clinical Microbiome Unit (CMU), Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Gut Microbes
|May 14, 2024
PubMed

Insights

Vaginal seeding, exposing C-section infants to maternal microbes, may reduce metabolic disease risk. Studies show it can decrease abdominal fat in male mice, suggesting positive impacts on metabolic health.

Area of Science:

  • Microbiome research
  • Metabolic disease research
  • Pediatric health

Background:

  • Cesarean section (C-section) delivery disrupts infant microbial colonization.
  • Vaginal seeding partially restores the infant gut microbiome.
  • The impact of vaginal seeding on long-term metabolic health remains unclear.

Purpose of the Study:

  • To investigate the effect of vaginal seeding on adiposity in a murine model.
  • To determine if early microbial colonization influences metabolic disease risk.

Main Methods:

  • Germ-free mice were colonized with stool from infants undergoing a double-blind randomized trial of vaginal seeding or placebo.
  • Intraabdominal adipose tissue (IAAT) volume was measured.
  • Metabolomic analysis was performed on fecal samples.

Main Results:

  • Male mice receiving stool from vaginally seeded infants showed reduced IAAT volume compared to controls.
  • Control mice exhibited higher isoleucine and lower nucleic acid metabolites.
  • These metabolic profiles correlated with increased IAAT in controls.

Conclusions:

  • Early gut microbiome and metabolome alterations via vaginal seeding may positively influence metabolic health.
  • Vaginal seeding shows potential in mitigating adiposity and associated metabolic risks.
  • Further research is warranted to confirm these findings in human infants.

Related Concept Videos